Clinical trial
Blockade of Vascular Potassium Channels During Human Endotoxemia
NCT00185003 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blockade of Vascular Potassium Channels During Human Endotoxemia
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- June 30, 2005
- Enrollment
- 36 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.